ArticleDiabetes, obesity & metabolism2021

Real-world use of cardioprotective glucose-lowering drugs in patients with type 2 diabetes and cardiovascular disease: A Danish nationwide cohort study, 2012 to 2019.

Kristian L Funck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.